OXT and depressive symptom measurement: Studies found that OXT methylation levels in MDD inpatients were significantly lower than in healthy controls, suggesting that changes in the epigenetic characteristics of the OXT system may constitute a vulnerability factor for susceptibility to depression (Sanwald and Widenhorn-Müller, 2020).